Lebanon Authorizes Use of Chinese Vaccine Sinopharm
A scientific committee formed by caretaker Health Minister Hamad Hassan on Monday granted emergency use authorization (EUA) to the Chinese anti-Covid vaccine Sinopharm.
The committee has been tasked with discussing the registration of vaccines submitted by the private sector.
Following the EUA, private companies can now sell the vaccine in the Lebanese market according to applicable regulations.
The decision was taken in a meeting chaired by Hassan and attended by the committee’s members -- Dr. Abdul Rahman al-Bizri, Dr. Maroun Zoghbi, Dr. Rony al-Zaani, Dr. Thuraya Dumyati, the representative of the Lebanese University Dr. Nazih Abu Chahine and the head of the pharmacy dept. at the Health Ministry, Dr. Colette Reaidi.
The Ministry had granted emergency use authorization for the Russian vaccine Sputnik V on February 5.
Lebanon’s national vaccination campaign began Feb. 14 and has been criticized as too slow and riddled by violations.
The World Bank has allocated $34 million to inoculate an initial two million of Lebanon's six million inhabitants free of charge with the Pfizer-BioNTech vaccine.